LRP4 and amyotrophic lateral sclerosis: AChR antibody pathogenicity in the context of MG is well documented, but it remains unclear in ALS, since passive transfer models using serum or IgG from AChR, as well as Lrp4 and Agrin antibody-positive ALS patients, have not yet been reported.